Clinical Trial Update: Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating induction chemoimmunotherapy in high-risk neuroblastoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Neuroblastoma

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Neuroblastoma, Ganglioneuroblastoma | Phase 3 | Status: RECRUITING